Cachet Pharmaceutical Co Ltd (SHE:002462) — Market Cap & Net Worth
Market Cap & Net Worth: Cachet Pharmaceutical Co Ltd (002462)
Cachet Pharmaceutical Co Ltd (SHE:002462) has a market capitalization of $589.07 Million (CN¥4.03 Billion) as of May 2, 2026. Listed on the SHE stock exchange, this China-based company holds position #11713 globally and #3582 in its home market, demonstrating a -1.57% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Cachet Pharmaceutical Co Ltd's stock price CN¥13.80 by its total outstanding shares 291707120 (291.71 Million). Analyse 002462 cash flow metrics to see how efficiently the company converts income to cash.
Cachet Pharmaceutical Co Ltd Market Cap History: 2015 to 2026
Cachet Pharmaceutical Co Ltd's market capitalization history from 2015 to 2026. Data shows change from $1.85 Billion to $589.07 Million (-8.68% CAGR).
Cachet Pharmaceutical Co Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Cachet Pharmaceutical Co Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.02x
Cachet Pharmaceutical Co Ltd's market cap is 0.02 times its annual revenue
Latest Price to Earnings (P/E) Ratio
3.43x
Cachet Pharmaceutical Co Ltd's market cap is 3.43 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $1.85 Billion | $8.20 Billion | $172.98 Million | 0.23x | 10.70x |
| 2016 | $1.57 Billion | $10.97 Billion | $223.10 Million | 0.14x | 7.02x |
| 2017 | $962.86 Million | $14.24 Billion | $263.64 Million | 0.07x | 3.65x |
| 2018 | $538.52 Million | $17.96 Billion | $327.63 Million | 0.03x | 1.64x |
| 2019 | $603.25 Million | $22.19 Billion | $659.80 Million | 0.03x | 0.91x |
| 2020 | $546.44 Million | $23.26 Billion | $590.90 Million | 0.02x | 0.92x |
| 2021 | $558.40 Million | $25.63 Billion | $601.88 Million | 0.02x | 0.93x |
| 2022 | $586.56 Million | $26.22 Billion | $468.31 Million | 0.02x | 1.25x |
| 2023 | $592.50 Million | $30.00 Billion | $250.06 Million | 0.02x | 2.37x |
| 2024 | $551.50 Million | $24.02 Billion | $160.67 Million | 0.02x | 3.43x |
Competitor Companies of 002462 by Market Capitalization
Companies near Cachet Pharmaceutical Co Ltd in the global market cap rankings as of May 2, 2026.
Key companies related to Cachet Pharmaceutical Co Ltd by market ranking:
- JD HEALTH INTL LTD (F:8ZN): Ranked #1408 globally with a market cap of $17.90 Billion USD ( €15.31 Billion EUR).
- Walgreens Boots Alliance Inc (NASDAQ:WBA): Ranked #2179 globally with a market cap of $10.37 Billion USD.
- ALIB.HL.INF.TEC.UNSP.ADR (F:TWYA): Ranked #2534 globally with a market cap of $8.42 Billion USD ( €7.20 Billion EUR).
- Raia Drogasil S.A (SA:RADL3): Ranked #2723 globally with a market cap of $7.53 Billion USD ( R$38.36 Billion BRL).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #1408 | JD HEALTH INTL LTD | F:8ZN | $17.90 Billion | €4.90 |
| #2179 | Walgreens Boots Alliance Inc | NASDAQ:WBA | $10.37 Billion | $11.98 |
| #2534 | ALIB.HL.INF.TEC.UNSP.ADR | F:TWYA | $8.42 Billion | €8.95 |
| #2723 | Raia Drogasil S.A | SA:RADL3 | $7.53 Billion | R$21.94 |
Cachet Pharmaceutical Co Ltd Historical Marketcap From 2015 to 2026
Between 2015 and today, Cachet Pharmaceutical Co Ltd's market cap moved from $1.85 Billion to $ 589.07 Million, with a yearly change of -8.68%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | CN¥589.07 Million | -3.90% |
| 2025 | CN¥612.97 Million | +11.15% |
| 2024 | CN¥551.50 Million | -6.92% |
| 2023 | CN¥592.50 Million | +1.01% |
| 2022 | CN¥586.56 Million | +5.04% |
| 2021 | CN¥558.40 Million | +2.19% |
| 2020 | CN¥546.44 Million | -9.42% |
| 2019 | CN¥603.25 Million | +12.02% |
| 2018 | CN¥538.52 Million | -44.07% |
| 2017 | CN¥962.86 Million | -38.54% |
| 2016 | CN¥1.57 Billion | -15.38% |
| 2015 | CN¥1.85 Billion | -- |
End of Day Market Cap According to Different Sources
On May 2nd, 2026 the market cap of Cachet Pharmaceutical Co Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $589.07 Million USD |
| MoneyControl | $589.07 Million USD |
| MarketWatch | $589.07 Million USD |
| marketcap.company | $589.07 Million USD |
| Reuters | $589.07 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Cachet Pharmaceutical Co Ltd
Cachet Pharmaceutical Co., Ltd. engages in the wholesale, retail, and logistics of pharmaceutical products in China. The company also offers medical devices. It sells its products through online and offline channels. The company was founded in 1997 and is headquartered in Beijing, China.